We are committed to building the next generation of highly targeted antibody therapeutics.

As part of our value-creation strategy, the company actively seeks strategic partnerships to broaden the application of our platform and advance high-potential product candidates. We are also actively seeking potential collaboration or licensing opportunities that would complement our existing portfolio. We are interested in building alliances that will enable us to realize our long-term vision of transforming lives with safer, more effective therapies.

If you are interested in partnering with us, please contact Siobhan Pomeroy, Senior Director, Business Development at CytomX.